Navigation Links
Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial
Date:6/19/2008

SYDNEY, Australia, June 19 /Xinhua-PRNewswire-FirstCall/ -- Pharmaxis (ASX: PXS; Nasdaq: PXSL) today announced that the company and the U.S. Food and Drug Administration (FDA) have reached agreement on the phase 3 registration trial of Bronchitol for bronchiectasis via the Special Protocol Assessment process.

The SPA process allows for FDA evaluation of a clinical trial protocol intended to form the primary basis of an efficacy claim in support of a New Drug Application, and provides an agreement that the study design, including trial size, clinical endpoints and/or data analyses are acceptable to the FDA.

Pharmaxis previously agreed on the trial design with the European regulatory agency (EMEA). This trial will therefore form the basis of a marketing application in both the U.S. and Europe.

The phase 3 trial has been designed in collaboration with internationally renowned experts in the field of bronchiectasis and will be a randomized, placebo controlled, double-blind investigation of Bronchitol twice daily in approximately 350 adults with bronchiectasis. Participants will be treated for 52 weeks and the primary endpoints are reduction in frequency of exacerbations and improvement in quality of life. Secondary endpoints include time to first exacerbation and duration of exacerbation. Additional secondary endpoints are antibiotic use, sputum volume, exercise tolerance and lung function measurements. The trial includes health economic analysis and will be conducted in centers across Europe and the U.S.

This trial is the second Phase III study to be undertaken for Bronchitol in bronchiectasis and follows the completion of a successful shorter trial reported last year.

Pharmaxis CEO, Alan Robertson, said the company was pleased to have concluded its discussions with the FDA and the EMEA.

''We believe this phase 3 trial design will allow us to thoroughly demonstrate the clinical benefits of Bronchitol in a patient populat
'/>"/>

SOURCE Pharmaxis Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pharmaxis Establishes Named Patient Program for Bronchitol
2. Pharmaxis Long-Term Safety Study of Bronchitol Completes
3. Alseres Pharmaceuticals Concludes Enrollment in the Cethrin(R) Phase I/IIa Clinical Trial in Acute Spinal Cord Injury
4. FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium)
5. Karmanos Doctors Urge Increased Screening for Previously Treated Lung Cancer Patients, Especially Young Women
6. Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations
7. Diplomat Specialty Pharmacy Develops and Launches Best-In-Class Electronic Navigator (eNAV(TM)) Patient Care System
8. Texas Heart(R) Institute at St. Lukes Episcopal Hospital Initiates First Clinical Trial in the World to Treat a Heart Attack Patient with a Special Stem Cell Type
9. Most Back Pain Could Be Cured Without Surgery or Drugs if Doctors Treated Muscles - Not the Spine - Says Leading Pain Specialist
10. Specialized Genasense(R) Clinical Trials Featured at AACR Meeting
11. Associated Foot & Ankle Specialists Enrolling Patients With Chronic Diabetic Foot Ulcers for MATRIX Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... 2015 CVS Health Corporation (NYSE: CVS ... May 1, 2015, at 8:30 a.m. (EDT) with analysts ... An audio webcast of the conference call ... of the CVS Health website for all interested parties. ... webcast will be archived and available on the web ...
(Date:4/17/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/dl9gbg/admetoxicology ... Testing - Global Strategic Business Report" report to ... markets for ADME-Toxicology Testing in US$ Million by the ... Testing. The report provides separate comprehensive analytics ... Japan , Europe , ...
(Date:4/17/2015)... DIEGO , April 17, 2015  Trovagene, ... diagnostics, announced today that clinical data presented at ... that its urine-based Precision Cancer Monitoring ℠ ... and monitoring of EGFR T790M mutations ... Detection of EGFR T790M Mutation in Urinary ...
Breaking Medicine Technology:ADME-Toxicology Testing (In-Vivo, & In-Vitro) Market - Global Strategic Business Report 2015: Pharma Industry Renews Focus on Cost Optimization 2Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 2Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 3Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 4
... Intravenous Recombinant Factor IX (rFIX) Product for the Treatment ... Biopharmaceuticals, Inc., today announced the initiation of a Phase ... Factor IX (rFIX) product for control and prevention of ... is estimated that the market for therapies to treat ...
... the risk of cardiovascular hospitalization or death by 24 ... Sanofi-aventis (Paris Bourse: EURONEXT: SAN; and ... that the ATHENA trial was published in the New ... (dronedarone), in addition to standard therapy, significantly reduced the ...
Cached Medicine Technology:Inspiration Biopharmaceuticals, Inc. Initiates Phase 1 Clinical Trial of IB1001 for the Treatment of Hemophilia B 2New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation 2New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation 3New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation 4New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation 5New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation 6
(Date:4/19/2015)... 2015 A live auction will be held ... major hospital in Brooklyn, NY and other national consignors. Various ... lab, anesthesia, exam and much more. , The auction ... starting at 9:00am CDT each day. The equipment is at ... Park, IL 60160. Anyone can participate in the auction ...
(Date:4/18/2015)... For some people, tattoos are works of ... rest of their lives, as they have spent a great ... a great amount of thought on their designs. For others, ... them or simply want them removed for personal or professional ... and in 2012-13 there was a 43 percent increase in ...
(Date:4/18/2015)... April 18, 2015 Carinsurancehints.com has released a ... plans that offer financial protection against fire damage. ... pay benefits in case their vehicle is set intentionally on ... caused by rioting or by other things. , It ... on a single website http://www.carinsurancehints.com/ , in just ...
(Date:4/18/2015)... Lowcostcarinsuranceprice.com has released a new blog post explaining the ... prices . , Drivers who live in states ... to pay more for auto insurance plans that provide ... offer protection against vehicle theft. , Affordable auto ... single website: http://lowcostcarinsuranceprice.com/ . Drivers who own ...
(Date:4/18/2015)... More than 2000 styles of newly designed ... #1 online store carrying celebrity inspired special occasion dresses. ... their perfect dresses for their prom. For those who ... at TheCelebrityDresses.com would be an ideal choice. , ... dresses inspired by the most loved styles seen at ...
Breaking Medicine News(10 mins):Health News:Centurion to Sell Surplus Medical Equipment in Online and On-Site Auction 2Health News:Dennis Dass, M.D. is Shattering the Past While Revealing the Future 2Health News:Online Auto Insurance Quotes For Plans That Cover Fire Damages! 2Health News:High Rates Of Car Theft Can Have An Impact on Auto Insurance Prices! 2Health News:Prom Dresses 2015 on Sale at TheCelebrityDresses.com 2
... researchers have found that flu strains migrate back and forth ... This is contrary to the common belief that flu strains ... The research appeared online on Nov. 14 in ... It was supported in part by the Centers of ...
... first study using magnetic resonance imaging (MRI) to evaluate ... researchers from Mount Sinai School of Medicine have found ... to the initial dust cloud on September 11, 2001, ... data was presented at the American Heart Association,s Scientific ...
... Emory University School of Medicine have identified hepcidin, a ... a potential target for treating atherosclerosis. Suppressing hepcidin ... the white blood cells found in arterial plaques. Reducing ... cholesterol in a process called "reverse cholesterol transport," interfering ...
... HealthDay Reporter , TUESDAY, Nov. 15 (HealthDay News) -- ... immediately following the New York City terror attacks on Sept. ... warn. Those Ground Zero workers who got there first ... those who came on the scene after Sept. 13, and may ...
... stable cardiovascular disease who have a genetic variation that ... the standard daily dosage of this medication resulted in ... JAMA . The study is being released early ... Heart Association Scientific Sessions. "Variants in the ...
... international clinical trial has found that treatment with a ... delay the development of bone metastases in men with ... in The Lancet , is the first to ... the importance of targeting the bone microenvironment to prevent ...
Cached Medicine News:Health News:NIH grantees rebut theory that seasonal flu strains originate in tropical regions 2Health News:NIH grantees rebut theory that seasonal flu strains originate in tropical regions 3Health News:WTC workers exposed earlier to dust cloud have higher risk of atherosclerotic lesions 2Health News:Hormone that controls iron levels may be target for atherosclerosis treatment 2Health News:9/11 First Responders May Face Greater Heart Risks 2Health News:9/11 First Responders May Face Greater Heart Risks 3Health News:Increasing dosage of clopidogrel for patients with genetic variation improves response to medication 2Health News:Denosumab delays development of prostate cancer bone metastasis 2
Enzyme immunoassay for the quantitative determination of Gliadin-IgA antibodies in serum and plasma. This kit provides specific determination of gliadin antibodies by using highly purified gliadin....
Anti Gliadin IgG Enzyme Immunosay for quantitative determination of Gliadin-IgG antibodies in serum....
Anti Gliadin IgA Enzyme Immunosay for quantitative determination of Gliadin-IgG antibodies in serum....
... the proper work area solution to manage ... and efficient way.,The progressive semi-automated Urisys 1800 ... data flow, supported by optional barcode reader ... accelerates analysis while high quality chemistries provide ...
Medicine Products: